dc.contributor.author |
Sashidhara, K V |
|
dc.contributor.author |
Singh, S P |
|
dc.contributor.author |
Varshney, Salil |
|
dc.contributor.author |
Beg, Muheeb |
|
dc.contributor.author |
Gaikwad, A N |
|
dc.date.accessioned |
2017-05-30T07:37:21Z |
|
dc.date.available |
2017-05-30T07:37:21Z |
|
dc.date.issued |
2014 |
|
dc.identifier.citation |
European Journal of Medicinal Chemistry, 2014, 86, 570-7 |
en |
dc.identifier.uri |
http://hdl.handle.net/123456789/1692 |
|
dc.description.abstract |
In our efforts to develop safe and active chemical entities from nature, we first identified poliothrysoside (1), a phytoconstituent isolated from Flacourtia indica, possessing antidiabetic potential. Subsequently, fifteen derivatives (2-16) were synthesized to assess the activity profile of this class. All the compounds were analyzed for their glucose uptake potency in chronic insulin-induced insulin resistant 3T3-L1 adipocytes. Interestingly, compound 2 exhibited strong ability to increase the insulin sensitivity, primarily activating the AMPK signaling pathway and also inhibited the adipogenesis in 3T3-L1 adipocytes, in concentration dependent manner. Overall, these studies suggest the potential of poliothrysoside and its derivatives as promising leads for non-insulin dependent type 2 diabetes (T2D). |
en |
dc.format.extent |
493855 bytes |
|
dc.format.mimetype |
application/pdf |
|
dc.language.iso |
en |
en |
dc.relation.ispartofseries |
CSIR-CDRI communication no. 8757. |
en |
dc.subject |
Poliothrysoside |
en |
dc.subject |
Insulin resistance |
en |
dc.subject |
3T3-L1 adipocytes |
en |
dc.subject |
AMPK |
en |
dc.subject |
Non-insulin dependent type 2 diabetes |
en |
dc.title |
Poliothrysoside and its derivatives as novel insulin sensitizers potentially driving AMPK activation and inhibiting adipogenesis |
en |
dc.type |
Article |
en |